CRP and Sepsis: To compare the performance of DLL1 to other biomarkers of inflammation and sepsis, an analysis of patients with DLL1, PCT, WBC, and CRP available at baseline (n = 92; 51 septic patients, 41 infectious/non-infectious patients) was performed.